Latest evidence-based view
FEM · BUY
FEM (First Trust Emerging Markets AlphaDEX Fund) reweights stocks by momentum, quality, value or another systematic factor. One-month (+10.44%) and three-month (+0.98%) returns both align with BUY.
FEM currently supports a buy stance.
One-month (+10.44%) and three-month (+0.98%) returns both align with BUY.
The opposing case is clear: a factor regime change can cause prolonged relative underperformance. the 0.80% annual expense ratio is deducted throughout ownership. The stance remains tied to the observed price trend.
Use staged sizing and reassess when the one- and three-month trends no longer support this stance.